This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Simons WR, Hagan M.The cost-effectiveness of adding colesevelam hydrochloride to metformin in patients with type 2 diabetes who have not achieved optimal glycemic control. 69th Annual Scientific Sessions of the American Diabetes Association: 320 abstr. 1217-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
About this article
Cite this article
Colesevelam provides economic benefit in T2DM treatment. Pharmacoecon. Outcomes News 582, 4 (2009). https://doi.org/10.2165/00151234-200905820-00009
- Placebo Group
- Economic Benefit
- Glycaemic Control
- American Diabetes Association